Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01830764 · ClinicalTrials.gov registry record · Phase 1
Open-label Safety and Tolerability Study of LTS-PDT in Healthy Volunteers
A Phase 1 study, sponsored by Dermira.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT01830764 is a Phase 1 study that has completed, run by Dermira. The registered enrollment target is 12 participants.
The verdict
NCT01830764, a Phase 1 study, has completed, sponsored by Dermira.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is assess the safety and tolerability of lemuteporfin topical solution (LTS) with exposure to red light (PDT), when applied to the backs of healthy volunteers.
Interventions
- DRUG Red Light (PDT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2013-04 |
| Est. Completion | 2013-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01830764
The ClinicalTrials.gov registry entry for NCT01830764 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dermira, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Red Light (PDT) is the first listed.
NCT01830764 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01830764 about?
NCT01830764 is a clinical study titled "Open-label Safety and Tolerability Study of LTS-PDT in Healthy Volunteers". The purpose of this study is assess the safety and tolerability of lemuteporfin topical solution (LTS) with exposure to red light (PDT), when applied to the backs of healthy volunteers.
What is the current status of trial NCT01830764?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2013-04. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01830764?
The interventions under investigation include: Red Light (PDT) (DRUG).
Who is sponsoring clinical trial NCT01830764?
This trial is sponsored by Dermira, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.